Drug intelligence / Profile preview

R7-CLIC1pep-linked E3 ligase peptide

Development stage
Preclinical
Lead developer
Kyungpook National University
Modality
Peptides, PROTACs (E3 ligase recruitment) → Targeted Protein Degraders (TPDs) → Small Molecules, Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
Administration
Parenteral
01

Overview

R7-CLIC1pep-linked E3 ligase peptide is a peptide-based proteolysis-targeting chimera (ProTAC) designed to target and degrade chloride intracellular channel protein 1 (CLIC1). Developed by researchers at Kyungpook National University, the molecule consists of three functional components: a hepta-arginine (R7) cell-penetrating peptide to facilitate intracellular delivery, a CLIC1-binding peptide (CLIC1pep) identified through phage display, and an E3 ligase-recruiting peptide. CLIC1 is a metamorphic protein upregulated in various cancers, including hepatocellular carcinoma and lung cancer, where it promotes angiogenesis, migration, and metastasis. By recruiting an E3 ligase to CLIC1, this therapeutic candidate induces the ubiquitination and subsequent proteasomal degradation of the target protein, thereby inhibiting tumor cell migration and invasion.

02

Targets

CLIC1 (Chloride intracellular channel protein 1)E3 ligase (E3 ubiquitin ligases)

Beyond the preview

Go deeper on R7-CLIC1pep-linked E3 ligase peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on R7-CLIC1pep-linked E3 ligase peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call